Fate Therapeutics, Inc. (FATE) vs Larimar Therapeutics, Inc. (LRMR)
A side-by-side comparison of Fate Therapeutics, Inc. and Larimar Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FATE
Fate Therapeutics, Inc.
$2.39HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
LRMR
Larimar Therapeutics, Inc.
$2.85HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — FATE vs LRMR
growth of $100 · dividends reinvested · last 10yFATE -18.2% (-2.0%/yr)LRMR -93.1% (-23.5%/yr)FATE compounded faster over this window
Log scale — wide-divergence pair
FATE LRMR
FATE vs LRMR: by the numbers
- •LRMR is the larger company ($296M vs $278M market cap).
- •Both run net losses; LRMR's is the smaller (0.00% vs -1941.09% net margin).
Metrics side by side
Valuation
| Metric | FATE | LRMR |
|---|---|---|
| P/S ratio | 42.83 | N/A |
| P/B ratio | 1.81 | 2.32 |
Profitability
| Metric | FATE | LRMR |
|---|---|---|
| Gross margin | -94.12% | 0.00% |
| Operating margin | -2222.45% | 0.00% |
| Net margin | -1941.09% | 0.00% |
| ROE | -82.12% | -135.50% |
| ROIC | -58.72% | -136.49% |
Growth (annualized)
| Metric | FATE | LRMR |
|---|---|---|
| Revenue CAGR (5Y) | -32.98% | N/A |
| Total return CAGR (5Y) | -46.86% | -23.91% |
Frequently asked
- How have FATE and LRMR total returns compared?
- Over the past 10 years, FATE delivered -2.31% and LRMR delivered -23.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.